What’s Next? Five Things To Look Out For In November

Mylan-Upjohn’s Viatris Set To Emerge

 
• By Dean Rudge

In November, Generics Bulletin will host its seventh annual Global Generics & Biosimilars Awards, while the long-awaited merger of Mylan and Pfizer’s Upjohn is set to complete and third-quarter financial results dominate the landscape.

Whats_Next_2020_2
Q3 Results dominate the landscape as $12bn merger set to close • Source: Shutterstock

More from Generics

More from Products